Literature DB >> 20179744

Stickler syndrome caused by COL2A1 mutations: genotype-phenotype correlation in a series of 100 patients.

Kristien P Hoornaert1, Inge Vereecke, Chantal Dewinter, Thomas Rosenberg, Frits A Beemer, Jules G Leroy, Laila Bendix, Erik Björck, Maryse Bonduelle, Odile Boute, Valerie Cormier-Daire, Christine De Die-Smulders, Anne Dieux-Coeslier, Hélène Dollfus, Mariet Elting, Andrew Green, Veronica I Guerci, Raoul C M Hennekam, Yvonne Hilhorts-Hofstee, Muriel Holder, Carel Hoyng, Kristi J Jones, Dragana Josifova, Ilkka Kaitila, Suzanne Kjaergaard, Yolande H Kroes, Kristina Lagerstedt, Melissa Lees, Martine Lemerrer, Cinzia Magnani, Carlo Marcelis, Loreto Martorell, Michèle Mathieu, Meriel McEntagart, Angela Mendicino, Jenny Morton, Gabrielli Orazio, Véronique Paquis, Orit Reish, Kalle O J Simola, Sarah F Smithson, Karen I Temple, Elisabeth Van Aken, Yolande Van Bever, Jenneke van den Ende, Johanna M Van Hagen, Leopoldo Zelante, Riina Zordania, Anne De Paepe, Bart P Leroy, Marc De Buyzere, Paul J Coucke, Geert R Mortier.   

Abstract

Stickler syndrome is an autosomal dominant connective tissue disorder caused by mutations in different collagen genes. The aim of our study was to define more precisely the phenotype and genotype of Stickler syndrome type 1 by investigating a large series of patients with a heterozygous mutation in COL2A1. In 188 probands with the clinical diagnosis of Stickler syndrome, the COL2A1 gene was analyzed by either a mutation scanning technique or bidirectional fluorescent DNA sequencing. The effect of splice site alterations was investigated by analyzing mRNA. Multiplex ligation-dependent amplification analysis was used for the detection of intragenic deletions. We identified 77 different COL2A1 mutations in 100 affected individuals. Analysis of the splice site mutations showed unusual RNA isoforms, most of which contained a premature stop codon. Vitreous anomalies and retinal detachments were found more frequently in patients with a COL2A1 mutation compared with the mutation-negative group (P<0.01). Overall, 20 of 23 sporadic patients with a COL2A1 mutation had either a cleft palate or retinal detachment with vitreous anomalies. The presence of vitreous anomalies, retinal tears or detachments, cleft palate and a positive family history were shown to be good indicators for a COL2A1 defect. In conclusion, we confirm that Stickler syndrome type 1 is predominantly caused by loss-of-function mutations in the COL2A1 gene as >90% of the mutations were predicted to result in nonsense-mediated decay. On the basis of binary regression analysis, we developed a scoring system that may be useful when evaluating patients with Stickler syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20179744      PMCID: PMC2987380          DOI: 10.1038/ejhg.2010.23

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  31 in total

1.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  Occurrence of deletion of a COL2A1 allele as the mutation in Stickler syndrome shows that a collagen type II dosage effect underlies this syndrome.

Authors:  Annemarie H Van Der Hout; Edwin Verlind; Frits A Beemer; Charles H C M Buys; Robert M W Hofstra; Hans Scheffer
Journal:  Hum Mutat       Date:  2002-09       Impact factor: 4.878

3.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 4.  Clinical variability of Stickler syndrome: role of exon 2 of the collagen COL2A1 gene.

Authors:  Larry A Donoso; Albert O Edwards; Arcilee T Frost; Robert Ritter; Nina Ahmad; Tamara Vrabec; Jerry Rogers; David Meyer; Scott Parma
Journal:  Surv Ophthalmol       Date:  2003 Mar-Apr       Impact factor: 6.048

5.  Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy).

Authors:  N N Ahmad; L Ala-Kokko; R G Knowlton; S A Jimenez; E J Weaver; J I Maguire; W Tasman; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes.

Authors:  A Ganguly; M J Rock; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Probabilistic prediction in patient management and clinical trials.

Authors:  D J Spiegelhalter
Journal:  Stat Med       Date:  1986 Sep-Oct       Impact factor: 2.373

8.  Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.

Authors:  Kazuhiko Takahara; Ulrike Schwarze; Yasutada Imamura; Guy G Hoffman; Helga Toriello; Lynne T Smith; Peter H Byers; Daniel S Greenspan
Journal:  Am J Hum Genet       Date:  2002-07-17       Impact factor: 11.025

9.  Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): a survey.

Authors:  G B Stickler; W Hughes; P Houchin
Journal:  Genet Med       Date:  2001 May-Jun       Impact factor: 8.822

Review 10.  Integration of splicing, transport and translation to achieve mRNA quality control by the nonsense-mediated decay pathway.

Authors:  Thomas Schell; Andreas E Kulozik; Matthias W Hentze
Journal:  Genome Biol       Date:  2002-02-26       Impact factor: 13.583

View more
  45 in total

1.  The expanding spectrum of COL2A1 gene variants IN 136 patients with a skeletal dysplasia phenotype.

Authors:  Mouna Barat-Houari; Bruno Dumont; Aurélie Fabre; Frédéric Tm Them; Yves Alembik; Jean-Luc Alessandri; Jeanne Amiel; Séverine Audebert; Clarisse Baumann-Morel; Patricia Blanchet; Eric Bieth; Marie Brechard; Tiffany Busa; Patrick Calvas; Yline Capri; François Cartault; Nicolas Chassaing; Vidrica Ciorca; Christine Coubes; Albert David; Anne-Lise Delezoide; Delphine Dupin-Deguine; Salima El Chehadeh; Laurence Faivre; Fabienne Giuliano; Alice Goldenberg; Bertrand Isidor; Marie-Line Jacquemont; Sophie Julia; Josseline Kaplan; Didier Lacombe; Marine Lebrun; Sandrine Marlin; Dominique Martin-Coignard; Jelena Martinovic; Alice Masurel; Judith Melki; Monique Mozelle-Nivoix; Karine Nguyen; Sylvie Odent; Nicole Philip; Lucile Pinson; Ghislaine Plessis; Chloé Quélin; Elise Shaeffer; Sabine Sigaudy; Christel Thauvin; Marianne Till; Renaud Touraine; Jacqueline Vigneron; Geneviève Baujat; Valérie Cormier-Daire; Martine Le Merrer; David Geneviève; Isabelle Touitou
Journal:  Eur J Hum Genet       Date:  2015-12-02       Impact factor: 4.246

2.  Association between SCO2 mutation and extreme myopia in Japanese patients.

Authors:  Tomotaka Wakazono; Masahiro Miyake; Kenji Yamashiro; Munemitsu Yoshikawa; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2016-04-06       Impact factor: 2.447

3.  Identification of an evolutionarily conserved regulatory element of the zebrafish col2a1a gene.

Authors:  Rodney M Dale; Jacek Topczewski
Journal:  Dev Biol       Date:  2011-06-25       Impact factor: 3.582

4.  Two novel COL2A1 mutations associated with a Legg-Calvé-Perthes disease-like presentation.

Authors:  Peter Kannu; Melita Irving; Salim Aftimos; Ravi Savarirayan
Journal:  Clin Orthop Relat Res       Date:  2011-03-26       Impact factor: 4.176

5.  ARCN1 Mutations Cause a Recognizable Craniofacial Syndrome Due to COPI-Mediated Transport Defects.

Authors:  Kosuke Izumi; Maggie Brett; Eriko Nishi; Séverine Drunat; Ee-Shien Tan; Katsunori Fujiki; Sophie Lebon; Breana Cham; Koji Masuda; Michiko Arakawa; Adeline Jacquinet; Yusuke Yamazumi; Shu-Ting Chen; Alain Verloes; Yuki Okada; Yuki Katou; Tomohiko Nakamura; Tetsu Akiyama; Pierre Gressens; Roger Foo; Sandrine Passemard; Ene-Choo Tan; Vincent El Ghouzzi; Katsuhiko Shirahige
Journal:  Am J Hum Genet       Date:  2016-07-28       Impact factor: 11.025

Review 6.  Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations.

Authors:  Marion Jeanne; Douglas B Gould
Journal:  Matrix Biol       Date:  2016-10-26       Impact factor: 11.583

7.  Splicing analysis of unclassified variants in COL2A1 and COL11A1 identifies deep intronic pathogenic mutations.

Authors:  Allan J Richards; Annie McNinch; Joanne Whittaker; Becky Treacy; Kim Oakhill; Arabella Poulson; Martin P Snead
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

8.  Auditory phenotype in Stickler syndrome: results of audiometric analysis in 20 patients.

Authors:  Frederic R Acke; Freya K Swinnen; Fransiska Malfait; Ingeborg J Dhooge; Els M R De Leenheer
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-19       Impact factor: 2.503

9.  Differential DNA methylation of vocal and facial anatomy genes in modern humans.

Authors:  David Gokhman; Malka Nissim-Rafinia; Lily Agranat-Tamir; Genevieve Housman; Raquel García-Pérez; Esther Lizano; Olivia Cheronet; Swapan Mallick; Maria A Nieves-Colón; Heng Li; Songül Alpaslan-Roodenberg; Mario Novak; Hongcang Gu; Jason M Osinski; Manuel Ferrando-Bernal; Pere Gelabert; Iddi Lipende; Deus Mjungu; Ivanela Kondova; Ronald Bontrop; Ottmar Kullmer; Gerhard Weber; Tal Shahar; Mona Dvir-Ginzberg; Marina Faerman; Ellen E Quillen; Alexander Meissner; Yonatan Lahav; Leonid Kandel; Meir Liebergall; María E Prada; Julio M Vidal; Richard M Gronostajski; Anne C Stone; Benjamin Yakir; Carles Lalueza-Fox; Ron Pinhasi; David Reich; Tomas Marques-Bonet; Eran Meshorer; Liran Carmel
Journal:  Nat Commun       Date:  2020-03-04       Impact factor: 14.919

10.  Hereditary pediatric cataract on the Arabian Peninsula.

Authors:  Arif O Khan
Journal:  Saudi J Ophthalmol       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.